Form 4: Saba Capital Increases Stake in Gabelli Healthcare & WellnessRx Trust

Saba Capital Management, L.P. reports acquiring additional shares of Gabelli Healthcare & WellnessRx Trust, increasing its beneficial ownership.

Summary

• On March 4, 2025, Saba Capital Management, L.P. acquired 4,388 shares of Gabelli Healthcare & WellnessRx Trust (GRX) common stock at a price of $9.96 per share.
• Following this transaction, Saba Capital Management, L.P. beneficially owns 1,937,507 shares of GRX.
• The reporting persons are Saba Capital Management, L.P. and Boaz Weinstein, both listed as directors and 10% owners.
• The filing indicates that the transaction was not made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. The sentiment is neither positive nor negative as it simply reports a transaction.

Positives

• Increased investment by Saba Capital could be interpreted as a positive signal for the fund's prospects.

Industry Context

Hedge funds like Saba Capital often take significant positions in closed-end funds like Gabelli Healthcare & WellnessRx Trust to influence fund strategy or capitalize on perceived undervaluation.

Stakeholder Impact

• The increased stake by Saba Capital could influence the market's perception of GRX, potentially affecting shareholder value.

Key Dates